Dr. Qiyu Wang, MD

Dr. Wang practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Wang's NPI, 1427579028, was assigned on July 5, 2017. Dr. Wang holds Massachusetts license 294816.

Dr. Wang's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Wang's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Wang is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Wang to 3 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Wang's licenses on file in 2 states: Massachusetts and Illinois.

CMS data shows 722 Medicare services from Dr. Wang across 11 procedure codes in 2024, for 282 Medicare patients. Medicare paid $63,099 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 282 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 73, with 47% women.

In 2024, Dr. Wang wrote 440 Medicare Part D claims for 90 patients. 88% of them were for generic drugs. CMS names the drug for 348 of them, across 13 drugs with 11 or more claims each, at $37,832 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 26 papers to Dr. Wang, published from 2014 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Acute Kidney Injury, Renal Insufficiency, Chronic and Creatinine. Dr. Wang has published most often in Kidney Int Rep. Dr. Wang's most frequent co-authors are Meghan E. Sise, MD, Sandra M. Herrmann, MD and Ala Abudayyeh, MD.

CMS Open Payments shows 8 general payments to Dr. Wang from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 71% of the total. Travere Therapeutics, Inc. paid the most, $211.